CO5271737A1 - Tioamidas de oxazolidinona con substituyentes de piperazin-amida - Google Patents

Tioamidas de oxazolidinona con substituyentes de piperazin-amida

Info

Publication number
CO5271737A1
CO5271737A1 CO01009443A CO01009443A CO5271737A1 CO 5271737 A1 CO5271737 A1 CO 5271737A1 CO 01009443 A CO01009443 A CO 01009443A CO 01009443 A CO01009443 A CO 01009443A CO 5271737 A1 CO5271737 A1 CO 5271737A1
Authority
CO
Colombia
Prior art keywords
alkyl
thioamids
amida
oxazolidinone
piperazin
Prior art date
Application number
CO01009443A
Other languages
English (en)
Inventor
Jackson B Hester Jr
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CO5271737A1 publication Critical patent/CO5271737A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de fórmula I<EMI FILE="01009443_1" ID="1" IMF=JPEG >o una sal farmacéuticamente aceptable en donde:A es una estructura i, ii, iii, o iv:<EMI FILE="01009443_2" ID="2" IMF=JPEG >W es NHC(=S)R1, o -Y-het; siempre que cuando A es una estructura iv, W no es -Y-het;Y es NH, O, o S;R1 es H,NH2,NHC1-4 alquilo,C1-4 alquenilo,OC1-4 alquilo,SC1-4 alquilo,(CH2)n-C3-6 cicloalquilo, oC1-4 alquilo, opcionalmente sustituido con 1-3 F, 1-2 Cl o CN;R2 y R3 son independientemente H, F, CI o C1-2 alquilo;R4 es -C(=O)-CR5R6-O-R7,-C(=O)-CH2S(O)n-CH3,-C(=O)-CH2-S(=O)(=NR8)CH3,-C(=S)-R9,-C(=O)-CH2-O-R10,-C(=O)-(CH2)m-C(=O)-CH3,-C(=O)-(CH2OH)2-CH3,-C(=O)-CH2-CH2-OR14, o-CN;R5 es H;R6 es fenilo, bencilo, CH2OH o CH2OCH3; oR5 y R6 conjuntamente forman C3-5 cicloalquilo;R7 es H, CH3 o C1-4 alcanoilo;R8 es H, C1-4 alquilo, C1-4 alcanoilo, -C(=O)NH-C1-4 alquilo o -CO2C1-4 alquilo;R9 es C1-4 alquilo, CH2OR11, S-C1-4 alquilo, OC1-4 alquilo, o NR12R13;R10 es fenilo, -CO2-(CH2)2-OCH3, -P(=O)(OH)2, -C(=O)-NR12R13, o ...
CO01009443A 2000-02-10 2001-02-08 Tioamidas de oxazolidinona con substituyentes de piperazin-amida CO5271737A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18164000P 2000-02-10 2000-02-10

Publications (1)

Publication Number Publication Date
CO5271737A1 true CO5271737A1 (es) 2003-04-30

Family

ID=22665142

Family Applications (1)

Application Number Title Priority Date Filing Date
CO01009443A CO5271737A1 (es) 2000-02-10 2001-02-08 Tioamidas de oxazolidinona con substituyentes de piperazin-amida

Country Status (17)

Country Link
US (1) US20010047004A1 (es)
EP (1) EP1263742B1 (es)
JP (1) JP2003522763A (es)
KR (1) KR20020072311A (es)
CN (1) CN1395569A (es)
AR (1) AR029226A1 (es)
AT (1) ATE302762T1 (es)
AU (1) AU2001234428A1 (es)
BR (1) BR0107645A (es)
CA (1) CA2395648A1 (es)
CO (1) CO5271737A1 (es)
DE (1) DE60112903T2 (es)
ES (1) ES2248284T3 (es)
MX (1) MXPA02007719A (es)
NZ (1) NZ520696A (es)
PE (1) PE20011089A1 (es)
WO (1) WO2001058885A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465456B2 (en) * 2000-06-29 2002-10-15 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
ATE321024T1 (de) 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
WO2003072575A1 (en) 2002-02-28 2003-09-04 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
NZ535591A (en) * 2002-02-28 2006-07-28 Astrazeneca Ab Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
CA2478502A1 (en) * 2002-04-01 2003-10-09 Cadila Healthcare Limited Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
CA2492194A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoproteins sites
CA2492743A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them
AU2003253141A1 (en) * 2002-08-22 2004-03-11 Orchid Chemicals And Pharmaceuticals Ltd Novel antibacterial agents
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
BR0316483A (pt) 2002-11-21 2005-10-11 Upjohn Co Derivados de n-(4-(piperazin-1-il)-fenil-2-oxazolidinona-5-carboxami da e compostos relacionados como agentes antibacterianos
JP4607107B2 (ja) 2003-07-02 2011-01-05 メルク・シャープ・エンド・ドーム・コーポレイション シクロプロピル基置換されたオキサゾリジノン抗生物質およびこれらの誘導体
WO2005005420A1 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Cyclopropyl group substituted oyazolidinone antibiotics and derivatives thereof
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
EP1934237A2 (en) 2005-08-24 2008-06-25 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
DK1934238T3 (en) 2005-08-24 2017-09-18 Melinta Therapeutics Inc TRIAZOL COMPOUNDS AND METHODS FOR THE PREPARATION AND USE OF THESE
US20100210602A1 (en) * 2006-12-12 2010-08-19 The Johns Hopkins University PhoU (PerF), A PERSISTENCE SWITCH INVOLVED IN PERSISTER FORMATION AND TOLERANCE TO MULTIPLE ANTIBIOTICS AND STRESSES AS A DRUG TARGET FOR PERSISTER BACTERIA
JO2972B1 (en) 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
AR066911A1 (es) 2007-06-08 2009-09-23 Janssen Pharmaceutica Nv Derivados de piperidina / piperazina
WO2008148851A1 (en) 2007-06-08 2008-12-11 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
JP5443342B2 (ja) 2007-06-08 2014-03-19 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピペリジン/ピペラジン誘導体
EP2170874A4 (en) * 2007-06-22 2011-08-31 Orchid Res Lab Ltd NEW COMPOUNDS AND THEIR USE
JP5579170B2 (ja) 2008-06-05 2014-08-27 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Dgat阻害剤とppar作動薬を含有する薬剤組み合わせ物
CN115466253A (zh) * 2021-06-16 2022-12-13 沈阳药科大学 含二硫代氨基甲酸酯结构的噁唑烷酮类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO84456B (ro) * 1981-09-08 1984-08-30 Eli Lilly And Co Procedeu pentru prepararea unor derivati de cefalosporina tieno si furopiridiniu substituita
US6218413B1 (en) * 1997-05-30 2001-04-17 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
AU9001598A (en) * 1997-09-11 1999-03-29 Hokuriku Seiyaku Co. Ltd Thiourea derivatives
JPH11322729A (ja) * 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
JP2000204084A (ja) * 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
NZ515754A (en) * 1999-05-27 2003-10-31 Upjohn Co Bicyclic oxazolidinone compounds, pharmaceuticals thereof and their use as antibacterial agents

Also Published As

Publication number Publication date
NZ520696A (en) 2004-03-26
DE60112903D1 (de) 2005-09-29
BR0107645A (pt) 2002-10-08
CA2395648A1 (en) 2001-08-16
US20010047004A1 (en) 2001-11-29
ES2248284T3 (es) 2006-03-16
ATE302762T1 (de) 2005-09-15
EP1263742B1 (en) 2005-08-24
WO2001058885A1 (en) 2001-08-16
KR20020072311A (ko) 2002-09-14
AR029226A1 (es) 2003-06-18
DE60112903T2 (de) 2006-06-14
EP1263742A1 (en) 2002-12-11
JP2003522763A (ja) 2003-07-29
AU2001234428A1 (en) 2001-08-20
CN1395569A (zh) 2003-02-05
PE20011089A1 (es) 2001-10-04
MXPA02007719A (es) 2002-10-11

Similar Documents

Publication Publication Date Title
CO5271737A1 (es) Tioamidas de oxazolidinona con substituyentes de piperazin-amida
YU17591A (sh) Triazolni fungicidni agensi
CO5460265A1 (es) Compuestos quimicos
CO5261539A1 (es) Compuestos farmaceuticamente activos
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
DE69206274D1 (de) 3-ureido-benzodiazepinone verwendbar als cck- oder gastrin-antagonisten.
CO5140116A1 (es) Compuestos espiro derivados de imidazo-benzazepina con actividad antihistaminica y sus procesos de obtencion a partir de sus intermediarios de sintesis
CO5090837A1 (es) Derivados de 1,3,4-oxadiazolona
TW350838B (en) Quinoline derivatives
CO5040091A1 (es) Derivados de urea
EP1056700A4 (en) MEDICINAL USE OF PHENYLALCANOLS AND DERIVATIVES THEREOF
ATE97409T1 (de) Benzodiazepin-analoge.
CA2074039A1 (en) Antihypertensive combination
DK0831092T3 (da) Hydroquinonderivat og farmaceutisk anvendelse deraf
NZ335975A (en) Heterocyclic substituted pyrrolidine amide derivatives useful in treating respiratory diseases
DE69217148T2 (de) Isoxazole derivate als lichtschutzmittel
PE20010131A1 (es) Agentes inmunopotenciadores
ES8400849A1 (es) Procedimiento para la obtencion de oximinoacetanilidas sustituidas.
YU47530B (sh) 6-supstituisani-heksahidrobenz cd indoli i postupak za njihovo dobijanje
PH20225A (en) 1-(6,7-dimethoxyquinazol-4-yl) semicarbazides
RU93005133A (ru) Производные азола, способ их получения, фармацевтическая композиция
ES8103747A1 (es) Procedimiento para la preparacion de 5,6,7,8-tetrahidropira-zolo (3,4-b)(1,5)diazepin-1h,4h-5,7-dionas

Legal Events

Date Code Title Description
FC Application refused